&w=3840&q=100)
Here's why AstraZeneca Pharma share price is down over 2% today
Here's why AstraZeneca Pharma's share price declined today
The decline in the company's share price came as the company's shares traded ex-date following its announcement of dividend rewards of ₹32 per share for the financial year 2024–25 (FY25). Notably, the ex-dividend date marks the day a stock begins trading without the value of its declared dividend. To be eligible for the dividend, investors must own the stock before the ex-dividend date.
AstraZeneca Pharma dividend record date
AstraZeneca Pharma dividend history
The company has a strong history of awarding dividends. According to NSE data, it paid ₹8 per share in 2022, ₹16 per share in 2023, and ₹24 per share in 2024 to its shareholders.
AstraZeneca Pharma dividend yield
At the current market price, AstraZeneca Pharma has a dividend yield of 0.35 per cent.
About AstraZeneca Pharma
AstraZeneca Pharma, a subsidiary of AstraZeneca Plc (UK), is engaged in the manufacture, distribution, and marketing of pharmaceutical products, and coordinates clinical trial services with its overseas group company. The company operates across major therapeutic areas including oncology, alimentary & metabolism, cardiovascular, renal diabetes, respiratory, infections, neuroscience, and inflammation. As of July 18, the pharma major boasts a market capitalisation of ₹22,912.50 crore on the NSE.
AstraZeneca Pharma share price history
AstraZeneca Pharma's share price has appreciated 42 per cent year-to-date, compared to a 5 per cent gain in the benchmark Nifty50 during the same period. The shares scaled a 52-week high of ₹10,691 on June 13, 2025, and hit a 52-week low of ₹6,220 on November 21, 2024, on the NSE.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Mint
28 minutes ago
- Mint
Delhivery bets on rapid commerce for growth, logs ₹91 crore net profit in Q1
Logistics major Delhivery is accelerating its push into new-age delivery models, capitalizing on the rise of quick commerce and expanding its partial truckload (PTL) capabilities. In the first quarter (April-June) of FY26, the company made strategic investments of ₹ 14 crore into two emerging services: Rapid Commerce, a 2-hour delivery service, and Delhivery Direct, which is an on-demand intracity shipment service. 'The real opportunity lies in servicing large brands working with quick commerce platforms—whether FMCG, grocery, or packaged food by offering high-precision, appointment-based deliveries to—and returns from—dark stores and mother warehouses. Quick commerce has created a new channel and incremental demand. Though our entry is just 100 days old, it's already become an exciting growth driver within our PTL business,' said Sahil Barua, chief executive of Delhivery, in an April-June earnings call on Friday. Delhivery reported a 68.5% surge in net profit in April-June to ₹ 91 crore. The company's operating revenue increased by 6% year-on-year to ₹ 2,294 crore. Shares of Delhivery settled 1% lower at ₹ 429.85 apiece on the BSE on Friday. A partial truckload business is a logistics service model that sits between LTL (less-than-truckload) and FTL (full truckload). It caters to medium-sized shipments that don't require an entire truck but are too large or bulky for standard parcel delivery. He added that quick commerce, however, remains largely concentrated in grocery, packaged foods, and BPC (beauty and personal care) segments, and is primarily active in major urban centres. While it has likely had a notable effect on grocery GMV (gross merchandise value) and order volumes for large marketplaces, its influence on broader e-commerce is expected to be limited. This is due to the inherent challenge of balancing wide product assortments with rapid delivery timelines, especially across increasingly dispersed urban geographies. More significantly, the bulk of e-commerce volumes comes from small cities (tier 2–4) and is fuelled by low-velocity, long-tail categories like apparel, accessories, and home and lifestyle products. These categories have unpredictable demand patterns and are not easily or economically suited to stocking in small quantities across dark stores. As a result, the company expects minimal impact from quick commerce on their overall volume trajectory moving forward. Low-velocity, long-tail refers to slower-selling, niche products like apparel that have unpredictable demand but collectively drive a large share of e-commerce volumes, especially in small cities. Delhivery's Rapid network currently operates 20 dark stores across three cities, offering shared inventory infrastructure and 1–3 hour fulfillment for direct-to-consumer brands. Plans are in place to scale this to 35–40 dark stores across six cities by Q4 FY26. While expected to remain a niche offering within Delhivery's broader Express portfolio, Rapid could generate ₹ 80–100 crore in revenue over time, the company said in a shareholder's letter. 'The network will serve as a foundation for Rapid B2B fulfillment, targeting time-critical segments such as auto parts, electronics spares, tyres, specialty chemicals, lubricants, and select FMCG products,' Barua said during the earnings call. Delhivery Direct, the company's consumer-facing app for on-demand inter-city shipping, has now expanded to include intra-city delivery as well. As these offerings are still in early stages, further investment—particularly in fleet capacity and demand generation for Delhivery Direct—is expected through FY26, said Barua. In January-March of FY25, Delhivery turned profitable for the first time, posting a net profit of ₹ 72.6 crore as revenue rose 6% year-on-year. Delhivery acquired rival logistics firm Ecom Express in an all-cash deal worth ₹ 1,407 crore in April. 'Obvious immediate impact of the Ecom acquisition will be clear in the Q2 numbers', said Barua.
Business Standard
an hour ago
- Business Standard
Hexaware Appoints Shantanu Baruah to Lead Healthcare, Life Sciences, and Insurance Globally
PRNewswire Iselin (New Jersey) [US], August 1: Hexaware Technologies (NSE: HEXT), a global IT solutions company, today announced the appointment of Shantanu Baruah as President & Global Head - Healthcare, Life Sciences & Insurance (H & I). He will be based out of the company's New Jersey office and will lead Hexaware's global strategy, growth, and client success initiatives across the vertical. With over 25 years of experience in the healthcare and life sciences industry, Shantanu brings deep domain expertise and a proven track record of building high-performing teams, driving strategic growth, and leading complex client transformations. Prior to joining Hexaware, he served as Executive Vice President at HCLTech, where he led the Healthcare vertical during one of the industry's most disruptive periods and played a pivotal role in expanding business in the Americas. At a time when AI is reshaping everything from drug discovery to diagnostics and preventive care, Shantanu's appointment underscores Hexaware's commitment to delivering real-world impact. With AI and data at the core, Hexaware is focused on helping clients enhance patient outcomes, accelerate innovation, and drive operational efficiencies -- critical pillars shaping the future of healthcare. R Srikrishna, CEO of Hexaware, said, "We're excited to have Shantanu join Hexaware at a time of exciting momentum in our Healthcare, Life Sciences, and Insurance business. His leadership and deep market knowledge will be instrumental in helping our clients navigate the next era of digital health, patient-centric care, and AI-powered innovation." Commenting on his appointment, Shantanu Baruah said, "I'm delighted to join Hexaware and lead the next phase of growth in the H & I vertical. The industry is at an inflection point, and Hexaware's agile culture, customer-first mindset, and AI-led and human intelligence perfected approach make it ideally positioned to partner with clients in delivering better outcomes." Shantanu holds a master's degree in computer applications and a bachelor's degree in zoology, a combination that brings both technical and scientific perspectives to his leadership. This appointment reflects Hexaware's continued focus on strengthening domain leadership and scaling vertical-centric growth to address the evolving needs of global clients. About Hexaware Hexaware is a global technology and business process services company. Every day, Hexawarians wake up with a singular purpose: to create smiles through great people and technology. With offices across the world, we empower enterprises worldwide to realize digital transformation at scale and speed by partnering with them to build, transform, run, and optimize their technology and business processes. Learn more about Hexaware at Photo: Logo:
The Print
an hour ago
- The Print
Markets extend losses on global sell-off amid US tariff concerns; Sensex tanks 586 points
As many as 2,712 stocks declined while 1,306 advanced and 151 remained unchanged on the BSE. Besides, persistent selling by foreign investors added to the gloom, according to experts. In a volatile trade, the 30-share BSE Sensex tumbled 585.67 points or 0.72 per cent to settle at 80,599.91. During the day, it dropped 690.01 points or 0.84 per cent to 80,495.57. Mumbai, Aug 1 (PTI) Equity benchmark indices Sensex and Nifty declined sharply for the second straight session on Friday, tracking deep losses in pharma, metal, and IT stocks amid trade-related concerns and widespread selling pressure in global markets. The 50-share NSE Nifty declined 203 points or 0.82 per cent to 24,565.35. 'The benchmark index Nifty wrapped up its fifth consecutive week in the red — its longest losing streak since August 2023, raising eyebrows across the street…Despite making multiple attempts to scale up, the index has struggled to hold ground, only to be met with selling pressure each time. The long upper wicks are a telling story — bulls tried, but bears had the final say,' Sudeep Shah, Head – Technical Research and Derivatives at SBI Securities, said. On the weekly front, the BSE benchmark tanked 863.18 points or 1.05 per cent, and the Nifty dropped 271.65 points or 1.09 per cent. 'The Indian equity market extended its decline for a second day, pressured by renewed tariff threats and punitive duties that could undermine India's global trade competitiveness. Investor sentiment weakened further as FIIs now hold the second-highest net short position in derivatives, reflecting elevated caution. 'Globally, markets turned negative amid rising US inflation and trade tensions. While the sell-off was broad-based, FMCG stocks emerged as a defensive play, supported by attractive valuations, resilient demand, and relative immunity to external trade disruptions,' Vinod Nair, Head of Research, Geojit Investments Limited, said. US President Donald Trump unveiled sweeping new tariffs on dozens of countries, including 25 per cent duties for goods from India, marking a new era of American protectionism that triggered fresh tensions and concerns over a much wider disruption in the global trade landscape. From the Sensex firms, Sun Pharma tumbled 4.43 per cent after the company reported a 20 per cent year-on-year decline in consolidated net profit to Rs 2,279 crore for the first quarter ended June 30, 2025. Tata Steel, Maruti, Tata Motors, Infosys, Bharti Airtel and Tech Mahindra were also among the laggards. However, Trent, Asian Paints, Hindustan Unilever, ITC, Kotak Mahindra Bank, and Reliance Industries were the gainers. The BSE smallcap gauge dropped 1.59 per cent, and the midcap index declined by 1.37 per cent. Healthcare tanked 2.44 per cent, telecommunication (2.41 per cent), metal (1.94 per cent), oil & gas (1.91 per cent), teck (1.83 per cent), IT (1.81 per cent), and realty (1.78 per cent). BSE FMCG index emerged as the only gainer. 'Markets began the August series on a negative note, extending the prevailing corrective trend, and ended lower by over half a per cent. Markets continue to grapple with a mixed earnings season, while the recent tariff announcement and persistent foreign fund outflows are further weighing on sentiment,' Ajit Mishra – SVP, Research, Religare Broking Ltd, said. The US president signed an executive order on Thursday that raised tariffs for over five dozen countries, with Washington's negotiations for trade deals going down to the wire ahead of the August 1 deadline. In the Executive Order titled 'Further Modifying The Reciprocal Tariff Rates', Trump announced tariff rates for nearly 70 nations. A 25 per cent 'Reciprocal Tariff, Adjusted' has been imposed on India, according to the list released. The order, however, does not mention the 'penalty' that Trump had said India would have to pay because it purchases Russian military equipment and energy. While August 1 was the tariff deadline, the new levies will come into effect from August 7. Foreign Institutional Investors (FIIs) offloaded equities worth Rs 5,588.91 crore on Thursday, according to exchange data. 'Global equity markets were mostly weak over the past week, as the US tariff saga continued. The Indian equity market continued to underperform global equity markets in the past week and was down 0.8 per cent over this period,' Shrikant Chouhan, Head – Equity Research, said. In Asian markets, South Korea's Kospi, Japan's Nikkei 225 index, Shanghai's SSE Composite index and Hong Kong's Hang Seng settled lower. Equity markets in Europe were trading in the red. The US markets ended in negative territory on Thursday. Global oil benchmark Brent crude declined 0.39 per cent to USD 71.42 a barrel. On Thursday, the Sensex declined 296.28 points or 0.36 per cent to settle at 81,185.58. The Nifty dropped 86.70 points or 0.35 per cent to 24,768.35. PTI SUM SUM BAL BAL This report is auto-generated from PTI news service. ThePrint holds no responsibility for its content.
